12240 Federal Register / Vol. 60, No. 43 / Monday, March 6, 1995 / Notices

Guam

Mr. Michael J. Reidy, Director, Bureau of

Budget and Management Research, Office

of the Governor, P.O. Box 2950, Agana,

Guam 96910, Telephone (671) 472–2285

Northern Mariana Islands

State Single Point of Contact, Planning and

Budget Office, Office of the Governor,

Saipan, CM, Northern Mariana Islands

96950

Puerto Rico

Norma Burgos/Jose H. Caro, Chairman/

Director, Puerto Rico Planning Board,

Minillas Government Center, P.O. Box

41119, San Juan, Puerto Rico 00940–9985,

Telephone (809) 727–4444

Virgin Islands

Jose L. George, Director, Office of

Management and Budget, #41 Norregade

Emancipation Garden Station, Second

Floor, Saint Thomas, Virgin Islands 00802

Please direct correspondence to:

Linda Clarke, Telephone (809) 774–0750

Attachment F

Certification Regarding Environmental

Tobacco Smoke

Public Law 103–227, Part C—

Environmental Tobacco Smoke, also known

as the Pro-Children Act of 1994 (Act),

requires that smoking not be permitted in any

portion of any indoor facility owned or

leased or contracted for by an entity and used

routinely or regularly for the provision of

health, day care, education, or library

services to children under the age of 18, if

the services are funded by Federal programs

either directly or through State or local

governments, by Federal grant, contract, loan,

or loan guarantee. The law does not apply to

children’s services provided in private

residences, facilities funded solely by

Medicare or Medicaid funds, and portions of

facilities used for inpatient drug or alcohol

treatment. Failure to comply with the

provisions of the law may result in the

imposition of a civil monetary penalty of up

to $1000 per day and/or the imposition of an

administrative compliance order on the

responsible entity.

By signing and submitting this application

the applicant/grantee certifies that it will

comply with the requirements of the Act. The

applicant/grantee further agrees that it will

require the language of this certification be

included in any subawards which contain

provisions for children’s services and that all

subgrantees shall certify accordingly.

[FR Doc. 95–5409 Filed 3–3–95; 8:45 am]

BILLING CODE 4184–01–P

Commission on Child and Family

Welfare; Hearing

AGENCY: Administration for Children

and Families, DHHS.

ACTION: Notice of public hearings.

SUMMARY: The Commission on Child

and Family Welfare will hold Public

Hearings at the following locations:

On March 28–29, 1995—Alexandria,

Virginia, Embassy Suites Hotel, 1900

Diagonal Road

On April 19–20, 1995—Cleveland, Ohio,

Forum Conference Center, 1

Cleveland Center, 1375 E. 9th Street

On May 9–10, 1995—San Francisco,

California, Holiday Inn Golden

Gateway, 1500 Van Ness Avenue

Mission

Creating environments in which

decisions can best be made about the

well-being of children that ensure that

children get emotional and financial

support from both parents.

Subject of Hearings: Custody and

Visitation

A. Laws, Policies and Procedures

• determination of how custody and

visitation decisions are made and

enforced;

• examination of alternative dispute

resolution models, standards and

guidelines;

• examination of (interstate) mobility

factors of parents and children;

• examination of the effectiveness of

putative fathers’ registries in

custody and visitation.

B. Community-Based Alternatives and

Support Systems

• examination of community support

systems and resources available to

parents and families with custody

and visitation issues.

C. Child Well-Being Issues:

Strengthening the Family

• examination of special populations

including: remarried, adoption,

domestic violence, immigration,

racial and ethnic factors that affect

custody and visitation;

• examination of research concerning

child adjustment associated with

various custody and visitation

approaches;

• examination of the dynamics of the

absent father syndrome; and

• examination of public policies and

procedures working against the

viability and support of two-parent

families.

Guidelines for Public Participation

Persons wishing to provide oral

testimony on the subject areas specified

above should make a request in writing

prior to the hearings by the following

dates:

For Alexandria, Virginia—March 17

For Cleveland, Ohio—April 5

For San Francisco, California—April 25

Send your request to: U.S.

Commission on Child and Family

Welfare, 370 L’Enfant Promenade, SW.,

Aerospace Building, Room 616,

Washington, DC 20447, Phone: (202)

401–5565. Witnesses will be notified of

the time of their appearance. Oral

testimony may be limited due to time

constraints. To ensure thorough

consideration of all viewpoints,

witnesses and other interested

individuals should submit written

testimony for inclusion in the printed

record of the hearing. Written testimony

will be accepted before, but not later

than 7 days following, each public

hearing. If a sign language interpreter is

needed, contact Kevin Costigan at (202)

401–5565 no later than 14 days prior to

each meeting.

FOR FURTHER INFORMATION CONTACT:

Kevin Costigan, Commission on Child

and Family Welfare, 370 L’Enfant

Promenade SW., Aerospace Bldg., 6th

Floor West, Room 616, Washington, DC

20447, (202) 401–5565.

SUPPLEMENTARY INFORMATION: None.

Dated: February 27, 1995.

Ann Rosewater,

Deputy Assistant Secretary for Policy and

External Affairs.

[FR Doc. 95–5333 Filed 3–3–95; 8:45 am]

BILLING CODE 4184–01–M

Food and Drug Administration

Memorandum of Understanding

Between the Food and Drug

Administration and the Environmental

Protection Agency

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is providing

notice of a memorandum of

understanding (MOU) between FDA and

the Environmental Protection Agency

(EPA). This action is necessary to

establish the working arrangements and

responsibilities of the two agencies. The

purpose of the MOU is to establish an

FDA liaison to the EPA Gulf of Mexico

Program Office.

DATES: The agreement became effective

September 29, 1994.

FOR FURTHER INFORMATION CONTACT:

Juanita Pointer, Center for Food Safety

and Applied Nutrition (HFS–669), Food

and Drug Administration, 200 C St. SW.,

Washington, DC 20204, 202–205–4098.

SUPPLEMENTARY INFORMATION: In

accordance with 21 CFR 20.108(c),

which states that all written agreements

and memoranda of understanding

between FDA and others shall be

published in the Federal Register, the

agency is publishing notice of this

memorandum of understanding.
Federal Register / Vol. 60, No. 43 / Monday, March 6, 1995 / Notices 12241

Dated: February 3, 1995,

Ronald G. Chesemore,

Associate Commissioner for Regulatory

Affairs.

Memorandum of Understanding Between

U.S. Department of Health and Human

Services, Public Health Service, Food and

Drug Administration and Environmental

Protection Agency, Gulf of Mexico Program

Purpose:

This Memorandum of Understanding

(MOU) is to establish the working

arrangements and responsibilities of the Food

and Drug Administration (FDA) and the

Environmental Protection Agency (EPA) for

the purpose of FDA providing a liaison to the

EPA Gulf of Mexico Program Office.

Background:

The Gulf of Mexico Program (GMP) was

established under the leadership of EPA to

develop a comprehensive, intergovernmental

strategy to protect and enhance the

environmental quality of the Gulf of Mexico.

The GMP identified priority issues of

environmental degradation and concern,

established a Gulf-wide committee

framework and infrastructure to ensure

communication and information exchange

and began implementing a 5-year strategy.

The strategy includes:

1. Preparation of environmental

characterization reports,

2. Preparation of environmental assessments,

3. Development of an interactive data

management system,

4. Preparation of predictive assessments,

5. Development of environmental

measurement plans and

6. Development of an environmental

monitoring system.

FDA’s Office of Seafood was established to

strengthen the agency’s domestic and

imported seafood programs. The Office of

Seafood coordinates all of FDA’s seafood

activities, including those which assure that

seafood does not contain harmful amounts of

natural or man-made substances, such as

toxins, pathogenic microorganisms,

industrial chemicals or toxic metals. FDA

uses several strategies to accomplish its

public health mission. One strategy is to

assist EPA in its Gulf of Mexico Program.

A. The Food and Drug Administration agrees

to:

1. Assign one individual to serve as the

principal liaison between FDA and the Gulf

of Mexico Program (GMP) with responsibility

for managing, coordinating, implementing

and evaluating FDA activities in support of

the GMP. The FDA liaison:

a. Provides program and technical assistance

and coordination of FDA activities with the

GMP Technical Steering Committee, Policy

Review Committee, technical steering

subcommittees and the State, local and

Federal agencies participating in the GMP.

b. Serves as Federal Co-Chair of the Public

Health Subcommittee with primary

responsibility for developing a Public Health

Action Plan for the Gulf of Mexico Program

and incorporating the recommendations of

the National Academy of Sciences Report on

Seafood Safety. The plan should address four

major elements, three of which are problems

for which FDA has the lead:

(1) Illnesses associated with consumption of

raw shellfish as a result of naturally

occurring pathogens and/or pathogens of

fecal origin.

(2) Risks associated with consumption of

Gulf of Mexico seafood contaminated with

toxic substances or pesticides.

(3) Effects of naturally occurring marine

biotoxins on the public health through direct

exposure via aerosols and/or exposure via

contaminated Gulf seafood.

(4) Illness associated with recreational or

occupational use of ambient waters

contaminated with sewage.

c. Coordinates, with other GMP participants,

the five major aspects of the GMP study:

Resource characterization and assessment;

problem identification and study design;

communication and education; integration

with ongoing programs of the Gulf; and

development of management,

implementation and monitoring strategies.

d. Evaluates technical documents developed

by the Technical Steering Subcommittees

and other agencies as they relate to public

health and GMP issues and for consistency

with FDA policies, programs and regulations.

e. Works closely with States to promote

cooperation and harmonization of their

public health programs as they relate to Gulf

of Mexico issues.

f. Serves as the FDA point of contact with

the National Shellfish Pollution Indicator

Study. Is responsible for keeping the GMP

informed of developments and providing

program needs to the Indicator Study

directors.

g. Develops appropriate projects to evaluate

programs and methods of reducing public

health risks associated with the use of the

waters and resources of the Gulf of Mexico.

h. Serves as project officer on extramural

projects to conduct scientific studies of

interest to FDA which relate to the Gulf of

Mexico Program.

2. Provide the following administrative

support to the assigned individual:

a. Salary—The FDA employee will remain

on the FDA payroll for the entire period

of the assignment.

b. Relocation Expenses—The cost of

relocating the FDA employee to the John C.

Stennis Space Center, Mississippi, as

provided by policies and procedures relating

to reporting to a duty station.

c. Travel Expenses—The FDA employee will

be provided transportation and per diem

expenses while in temporary duty status for

the entire period of the assignment.

d. Equipment—FDA will provide a personal

computer for use by the employee during

the entire period of the agreement.

3. Provide annual review of the

individual’s performance for the entire

period of the assignment.

4. Administrative Support—Annually

provide partial financial support to EPA/

GMP to defray part of the overall costs to

them for providing services as stated under

this IAG. Amount to be worked out between

the two agencies.

B. The Environmental Protection AgencyGulf of Mexico Program agrees to:

1. Provide technical supervision and assign

day-to-day tasks to the FDA representative to

the GMP. The technical and day-to-day

assignments will be provided by the Director

of the Gulf of Mexico Program; and he shall

serve as the EPA’s point of contact and the

liaison officer for this interagency agreement.

2. Provide the following administrative

support to the assigned individual:

a. Space—Space will be provided at the GMP

Headquarters at the John C. Stennis Space

Center; and the space will contain

appropriate furniture and conveniences.

b. Telecommunication—Telephone service

including FTS, Long Distance, and Fax will

be provided.

c. Secretarial Support—Secretarial support

will be provided to include: Typing,

xeroxing, dictating, filing, printing,

duplicating, and office supplies.

3. The Director, GMP, will provide FDA

with written comments on the individual’s

performance for the specified rating period.

The information will be used on the General

Workforce Performance Appraisal of the FDA

liaison.

Period of Agreement:

It is anticipated that this MOU will be for

approximately 5 years from the date of

signature. Modification of the MOU shall be

by mutual consent of the parties. However,

if either party desires to terminate this MOU,

a written notice to the other party shall be

forwarded and received 30 days in advance

of the desired termination date.

Approved and Accepted for the

Environmental Protection Agency Gulf of

Mexico Program

By: Douglas A. Lipka

Title: Acting Director

Date: September 29, 1994

Approved and Accepted for the Food and

Drug Administration

By: Fred R. Shank

Title: Director, Center for Food Safety and

Applied Nutrition
12242 Federal Register / Vol. 60, No. 43 / Monday, March 6, 1995 / Notices

Dated: September 22, 1994.

[FR Doc. 95–5309 Filed 3–3–95; 8:45 am]

BILLING CODE 4160–01–F

Health Resources and Services

Administration

Availability of Funds for the National

Health Service Corps Loan Repayment

Program and Grants for State Loan

Repayment Programs

AGENCY: Health Resources and Services

Administration, PHS.

ACTION: Notice.

SUMMARY: The Health Resources and

Services Administration (HRSA)

announces that approximately $42.4

million will be available in fiscal year

(FY) 1995 for: (1) Awards for

educational loan repayment under the

National Health Service Corps (NHSC)

Loan Repayment Program (LRP)

(Section 338B of the Public Health

Service (PHS) Act) and (2) grants to

States to operate loan repayment

programs (Section 338I of the PHS Act).

The HRSA, through this notice,

invites health professionals to apply for

participation in the NHSC LRP and

invites States to apply for grants to

operate State Loan Repayment Programs

(LRPs). The HRSA estimates that

approximately 550 NHSC Loan

Repayment awards totaling $35.4

million will be made to health

professionals providing primary health

services. Approximately $7 million in

discretionary grants will be available to

States to operate LRPs. Approximately

$3 million will be available to support

10 competing continuation grants and 3

to 5 new starts. The range for these

grants is approximately $20,000 to $1

million. Approximately $4 million is

available for 19 noncompeting

continuation grants. Awards will be

made for a 1-year budget period and for

up to a 5-year project period.

The PHS is committed to achieving

the health promotion and disease

prevention objectives of Healthy People

2000, a PHS-led national activity for

setting health priority areas. These

programs will contribute to the Healthy

People 2000 objectives by improving

access to primary health care services

through coordinated systems of care for

medically underserved populations in

both rural and urban areas. Potential

applicants may obtain a copy of Healthy

People 2000 (Full Report, Stock No.

017–001–00474–01) or Healthy People

2000 (Summary Report; Stock No. 017–

001–00473–1) through the

Superintendent of Documents,

Government Printing Office,

Washington, DC 20402–9325 (telephone

202–783–3238).

The Public Health Service strongly

encourages all grant recipients to

provide a smoke-free workplace and

promote the non-use of all tobacco

products. This is consistent with the

PHS mission to protect and advance the

physical and mental health of the

American people.

Part A of this notice contains specific

information concerning the NHSC LRP,

and Part B contains specific information

concerning grants for State LRPs.

Part A—NHSC Loan Repayment

Program

ADDRESSES: Application materials may

be obtained by calling or writing to:

National Health Service Corps Loan

Repayment Program, 8201 Greensboro

Drive, Suite 600, McLean, Virginia

22102, 1–800–221–9393 or (703) 734–

6855. Completed applications must be

returned to: Loan Repayment Programs

Branch, Division of Scholarships and

Loan Repayments, Bureau of Primary

Health Care, HRSA, 4350 East-West

Highway, 10th Floor, Bethesda,

Maryland 20814, (301) 594–4400. The

24-hour toll-free phone number is 1–

800–435–6464, and the FAX number is

301–594–4981. Applicants for the NHSC

LRP will use HRSA Form 873 approved

under Office of Management and Budget

(OMB) Number 0915–0127.

DATES: To receive consideration for

funding, health professionals must

submit their applications by August 1,

1995. To assure early processing of the

application and approval for site

matching, individuals are encouraged to

submit applications well ahead of the

August 1 deadline.

Applications will be considered to be

on time if they are either: (1) Received

on or before the deadline date; or (2)

postmarked on or before the established

deadline date and received in time for

orderly processing. Applicants should

request a legibly dated U.S. Postal

Service postmark or obtain a legibly

dated receipt from a commercial carrier

or U.S. Postal Service. Private metered

postmarks are not acceptable as proof of

timely mailing. Applications received

after the announced closing date will

not be considered for funding.

FOR FURTHER INFORMATION CONTACT: For

further program information and

technical assistance, please contact the

Loan Repayment Programs Branch at the

above address, phone or FAX number.

SUPPLEMENTARY INFORMATION: Section

338B of the PHS Act (42 U.S.C. 254l–1)

authorizes the Secretary to establish the

NHSC LRP to help in assuring, with

respect to the provision of primary

health services, an adequate supply of

trained primary care health

professionals for the NHSC. The NHSC

is used by the Secretary to provide

primary health services in federally

designated health professional shortage

areas (HPSAs). Primary health services

are services regarding family medicine,

general internal medicine, general

pediatrics, obstetrics and gynecology,

dentistry, or mental health, that are

provided by physicians or other health

professionals.

Under the NHSC LRP, the Secretary

will repay graduate and undergraduate

educational loans incurred by primary

care health professionals. For the first 2

years of full-time service at an approved

site in a designated HPSA, the Secretary

will repay up to $25,000 per year of the

educational loans of such individual.

(There is a minimum 2-year service

obligation.) For subsequent years of fulltime service, if the NHSC LRP contract

is extended, the Secretary will repay up

to $35,000 per year. Payments may be

made to participants on an advanced

quarterly basis (one quarter in advance

of service for the entire service

obligation), on an advanced annual

basis (one year in advance of service for

each year of service) or on an advanced

biennial basis (2 years in advance of

service but only for the first 2 years of

a contract). The Secretary shall, in

addition to such payments, make

payments to the individual in an

amount equal to 39 percent of the total

amount of loan repayments made for the

taxable year involved. In addition to

these amounts, NHSC LRP participants

will receive a salary from a private

nonprofit or public entity or, in some

cases, the Federal Government during

the term of their service.

The Secretary will identify and make

available annually a list of those HPSA

sites which will be available for service

repayment under the NHSC LRP. The

Secretary will select applicants for

consideration for participation in the

NHSC LRP according to the following

criteria:

(1) The extent to which an individual’s

training in a health profession or specialty is

determined by the Secretary to be needed by

the NHSC in providing primary health

services. From time to time, the Secretary

will publish a notice detailing the

professions and specialties most needed by

the NHSC. Current professional and specialty

priorities are outlined in this notice at the

end of Part A.

(2) The extent to which an individual is

determined by the Secretary to be committed

to serve in a HPSA.

(3) The extent of an individual’s

demonstrated interest in providing primary

health services.